---
figid: PMC4118478__668f1
figtitle: p53 at the crossroads of MPN treatment
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC4118478
filename: 668f1.jpg
figlink: /pmc/articles/PMC4118478/figure/FU1/
number: F1
caption: IFNα activates the JAK/STAT pathway, which leads to the translocation of
  STAT1/2 and IRF-9 to the nucleus that induces the p53 gene expression through the
  IFN-sensitive response element (ISRE) in its promoter. In parallel, at the level
  of JAK2V617F-positive stem or progenitor cells, the thrombopoietin (TPO) receptor
  activates downstream signaling pathways, especially the PI3K/AKT/mammalian target
  of rapamycin (mTOR) pathway. In turn, the translation of the ribonucleoprotein LA
  increases, resulting in enhancement of MDM2 translation and the degradation of p53
  tumor suppressor. The use of RG7112, an antagonist of MDM2, alleviates the p53 degradation
  and strongly contributes to increase the levels of p53 protein stimulated by INFα,
  triggering cell death and cell cycle arrest.
papertitle: p53 at the crossroads of MPN treatment.
reftext: Isabelle Plo. Blood. 2014 Jul 31;124(5):668-669.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9500099
figid_alias: PMC4118478__F1
figtype: Figure
redirect_from: /figures/PMC4118478__F1
ndex: 6be5bad3-def6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4118478__668f1.html
  '@type': Dataset
  description: IFNα activates the JAK/STAT pathway, which leads to the translocation
    of STAT1/2 and IRF-9 to the nucleus that induces the p53 gene expression through
    the IFN-sensitive response element (ISRE) in its promoter. In parallel, at the
    level of JAK2V617F-positive stem or progenitor cells, the thrombopoietin (TPO)
    receptor activates downstream signaling pathways, especially the PI3K/AKT/mammalian
    target of rapamycin (mTOR) pathway. In turn, the translation of the ribonucleoprotein
    LA increases, resulting in enhancement of MDM2 translation and the degradation
    of p53 tumor suppressor. The use of RG7112, an antagonist of MDM2, alleviates
    the p53 degradation and strongly contributes to increase the levels of p53 protein
    stimulated by INFα, triggering cell death and cell cycle arrest.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TPO
  - THPO
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - JAK2
  - JAK1
  - TYK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - STAT5A
  - STAT5B
  - AKT1
  - AKT2
  - AKT3
  - STAT1
  - STAT2
  - MTOR
  - IRF9
  - MDM2
  - TP53
  - TP63
  - TP73
  - tpo
  - thpo
  - jak2b
  - jak1
  - tyk2
  - stat5a
  - stat1a
  - stat1b
  - stat4
  - stat2
  - mtor
  - irf9
  - mdm2
  - tp53
  - RG7112
  - Cancer
---
